Johnson Investment Counsel Inc. increased its holdings in shares of Chemed Co. (NYSE:CHE) by 5.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,503 shares of the company’s stock after purchasing an additional 363 shares during the period. Johnson Investment Counsel Inc.’s holdings in Chemed were worth $3,086,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also modified their holdings of CHE. Keel Point LLC purchased a new position in Chemed in the second quarter valued at $24,504,000. Northwestern Mutual Wealth Management Co. increased its holdings in Chemed by 1,700.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 54 shares of the company’s stock valued at $26,000 after buying an additional 51 shares in the last quarter. Eagle Bay Advisors LLC purchased a new position in Chemed in the second quarter valued at $64,000. Advisory Services Network LLC purchased a new position in Chemed in the second quarter valued at $94,000. Finally, Jacobi Capital Management LLC increased its holdings in Chemed by 31.0% in the second quarter. Jacobi Capital Management LLC now owns 203 shares of the company’s stock valued at $96,000 after buying an additional 48 shares in the last quarter. 87.51% of the stock is owned by hedge funds and other institutional investors.
Separately, Royal Bank of Canada lifted their target price on shares of Chemed from $604.00 to $609.00 and gave the company an “outperform” rating in a research report on Thursday, July 29th.
Chemed (NYSE:CHE) last released its quarterly earnings results on Monday, July 26th. The company reported $4.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.29 by $0.31. The business had revenue of $532.26 million for the quarter, compared to the consensus estimate of $511.85 million. Chemed had a net margin of 14.30% and a return on equity of 35.40%. The business’s revenue was up 6.0% on a year-over-year basis. During the same period in the previous year, the firm earned $4.41 EPS. As a group, analysts anticipate that Chemed Co. will post 17.9 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, September 2nd. Investors of record on Monday, August 16th were paid a dividend of $0.36 per share. This is an increase from Chemed’s previous quarterly dividend of $0.34. This represents a $1.44 annualized dividend and a yield of 0.35%. The ex-dividend date was Friday, August 13th. Chemed’s dividend payout ratio is presently 7.96%.
In other Chemed news, CEO Kevin J. Mcnamara sold 3,000 shares of the business’s stock in a transaction that occurred on Monday, August 9th. The shares were sold at an average price of $467.78, for a total transaction of $1,403,340.00. Following the completion of the transaction, the chief executive officer now owns 128,688 shares in the company, valued at approximately $60,197,672.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.69% of the stock is owned by corporate insiders.
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
See Also: Quick Ratio
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.